Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

This story is part of the KXAN Data Hub, where numbers help tell the whole story. We’ve created several data-driven stories and databases on topics including weather and climate, politics, education, ...

Data center REITs profit from increasing data usage and AI growth, offering long-term leases for stable revenue. Interest rates and market oversupply present financial risks to data center REITs' ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

The Iran war sent oil futures surging to historic gains this week, while stocks fell sharply in a worldwide selloff. US stocks closed lower Friday as surging oil prices and weaker-than-expected jobs ...

A biotech CEO with decades of scientific experience but sporadic coding practice gained practical bioinformatics capabilities ...

Taylor Tepper covered banking, investing and pretty much everything else in personal finance for more than a decade, with his work appearing in the New York Times, Fortune and MONEY magazine, as well ...

Global growth is projected at 3.1 percent in 2024 and 3.2 percent in 2025, with the 2024 forecast 0.2 percentage point higher than that in the October 2023 World Economic Outlook (WEO) on account of ...